BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36455835)

  • 21. RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.
    Lou P; Li C; Shi L; Xia TS; Zhou W; Wu J; Zhou X; Li X; Wang Y; Wei JF; Ding Q
    Oncotarget; 2017 Mar; 8(10):16387-16400. PubMed ID: 27634883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
    Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
    J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.
    Fettig LM; McGinn O; Finlay-Schultz J; LaBarbera DV; Nordeen SK; Sartorius CA
    Oncogene; 2017 Nov; 36(44):6074-6084. PubMed ID: 28692043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of DNA methylation and histone acetylation in the regulation of progesterone receptor isoforms expression in human astrocytoma cell lines.
    Hansberg-Pastor V; González-Arenas A; Peña-Ortiz MA; García-Gómez E; Rodríguez-Dorantes M; Camacho-Arroyo I
    Steroids; 2013 May; 78(5):500-7. PubMed ID: 23474171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
    Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
    Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation.
    Liu R; Zhou Z; Zhao D; Chen C
    Mol Endocrinol; 2011 Jul; 25(7):1137-44. PubMed ID: 21566082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.
    Wiebe JP; Zhang G; Welch I; Cadieux-Pitre HA
    Breast Cancer Res; 2013 May; 15(3):R38. PubMed ID: 25927181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.
    De Amicis F; Zupo S; Panno ML; Malivindi R; Giordano F; Barone I; Mauro L; Fuqua SA; Andò S
    Mol Endocrinol; 2009 Apr; 23(4):454-65. PubMed ID: 19147702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of progesterone receptor isoforms content in human astrocytoma cell lines.
    Cabrera-Muñoz E; González-Arenas A; Saqui-Salces M; Camacho J; Larrea F; García-Becerra R; Camacho-Arroyo I
    J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):80-4. PubMed ID: 19095059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progesterone suppresses the invasion and migration of breast cancer cells irrespective of their progesterone receptor status - a short report.
    Godbole M; Tiwary K; Badwe R; Gupta S; Dutt A
    Cell Oncol (Dordr); 2017 Aug; 40(4):411-417. PubMed ID: 28653288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interplay between intracellular progesterone receptor and PKC plays a key role in migration and invasion of human glioblastoma cells.
    Marquina-Sánchez B; González-Jorge J; Hansberg-Pastor V; Wegman-Ostrosky T; Baranda-Ávila N; Mejía-Pérez S; Camacho-Arroyo I; González-Arenas A
    J Steroid Biochem Mol Biol; 2017 Sep; 172():198-206. PubMed ID: 27717886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid and mineralocorticoid cross-talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cells.
    Leo JC; Guo C; Woon CT; Aw SE; Lin VC
    Endocrinology; 2004 Mar; 145(3):1314-21. PubMed ID: 14617569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
    Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
    Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERα-36 regulates progesterone receptor activity in breast cancer.
    Konan HP; Kassem L; Omarjee S; Surmieliova-Garnès A; Jacquemetton J; Cascales E; Rezza A; Trédan O; Treilleux I; Poulard C; Le Romancer M
    Breast Cancer Res; 2020 May; 22(1):50. PubMed ID: 32429997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of progesterone receptor isoforms A and B is differentially regulated by estrogen in different breast cancer cell lines.
    Vienonen A; Syvälä H; Miettinen S; Tuohimaa P; Ylikomi T
    J Steroid Biochem Mol Biol; 2002 Mar; 80(3):307-13. PubMed ID: 11948015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes.
    Clarke CL; Graham JD
    PLoS One; 2012; 7(4):e35859. PubMed ID: 22545144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid Actions of the Nuclear Progesterone Receptor through cSrc in Cancer.
    Bello-Alvarez C; Zamora-Sánchez CJ; Camacho-Arroyo I
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer.
    Rahman MT; Nakayama K; Ishikawa M; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Iida K; Miyazaki K
    Oncology; 2013; 84(3):166-73. PubMed ID: 23306391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms.
    Hardy DB; Janowski BA; Chen CC; Mendelson CR
    Mol Endocrinol; 2008 Aug; 22(8):1812-24. PubMed ID: 18483177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.